[go: up one dir, main page]

SI0923566T1 - High molecular weight polymer-based prodrugs - Google Patents

High molecular weight polymer-based prodrugs

Info

Publication number
SI0923566T1
SI0923566T1 SI9730607T SI9730607T SI0923566T1 SI 0923566 T1 SI0923566 T1 SI 0923566T1 SI 9730607 T SI9730607 T SI 9730607T SI 9730607 T SI9730607 T SI 9730607T SI 0923566 T1 SI0923566 T1 SI 0923566T1
Authority
SI
Slovenia
Prior art keywords
molecular weight
high molecular
substituted
weight polymer
based prodrugs
Prior art date
Application number
SI9730607T
Other languages
English (en)
Slovenian (sl)
Inventor
Richard B. Greenwald
Annapurna Pendri
Hong Zhao
Original Assignee
Enzon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzon, Inc. filed Critical Enzon, Inc.
Publication of SI0923566T1 publication Critical patent/SI0923566T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyethers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
SI9730607T 1996-08-20 1997-08-20 High molecular weight polymer-based prodrugs SI0923566T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/700,269 US5840900A (en) 1993-10-20 1996-08-20 High molecular weight polymer-based prodrugs
EP97938484A EP0923566B1 (fr) 1996-08-20 1997-08-20 Promedicaments a base de polymere a poids moleculaire eleve
PCT/US1997/014692 WO1998007713A1 (fr) 1996-08-20 1997-08-20 Promedicaments a base de polymere a poids moleculaire eleve

Publications (1)

Publication Number Publication Date
SI0923566T1 true SI0923566T1 (en) 2004-04-30

Family

ID=24812855

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730607T SI0923566T1 (en) 1996-08-20 1997-08-20 High molecular weight polymer-based prodrugs

Country Status (13)

Country Link
US (1) US5840900A (fr)
EP (1) EP0923566B1 (fr)
JP (2) JP5008783B2 (fr)
AT (1) ATE253060T1 (fr)
AU (1) AU730244B2 (fr)
CA (1) CA2263409C (fr)
DE (1) DE69725862T2 (fr)
DK (1) DK0923566T3 (fr)
ES (1) ES2210564T3 (fr)
NZ (1) NZ334283A (fr)
PT (1) PT923566E (fr)
SI (1) SI0923566T1 (fr)
WO (1) WO1998007713A1 (fr)

Families Citing this family (182)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100361933B1 (ko) 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US5965566A (en) * 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
PT932399E (pt) * 1996-03-12 2006-05-31 Pg Txl Co Lp Pro-farmacos de paclitaxel hidrossoluveis
US6214966B1 (en) * 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
US20050158273A1 (en) * 1997-09-25 2005-07-21 Harris J. M. Soluble, degradable polyethylene glycol) derivatives for controllable release of bound molecules into solution
US6011042A (en) * 1997-10-10 2000-01-04 Enzon, Inc. Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
US6111107A (en) * 1997-11-20 2000-08-29 Enzon, Inc. High yield method for stereoselective acylation of tertiary alcohols
US6180095B1 (en) * 1997-12-17 2001-01-30 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
CA2312975C (fr) 1997-12-17 2012-08-21 Enzon, Inc. Prodrogues polymeriques d'agents bioactifs contenant amine ou hydroxy
DK1053019T3 (da) * 1998-01-07 2004-04-13 Debio Rech Pharma Sa Nedbrydelige heterobifunktionelle polyethylenglycolacrylater og geler og konjugater afledt derfra
US6153655A (en) * 1998-04-17 2000-11-28 Enzon, Inc. Terminally-branched polymeric linkers and polymeric conjugates containing the same
ES2242396T3 (es) 1998-04-28 2005-11-01 Applied Research Systems Ars Holding N.V. Conjugados de analogos de peg-lhrh.
US7953788B2 (en) * 2001-09-29 2011-05-31 Siebel Systems, Inc. System and method for queuing data for an application server
HK1042287A1 (zh) * 1999-06-08 2002-08-09 La Jolla Pharmaceutical Company 包括氨基氧基的化合价平台分子
WO2001005819A1 (fr) * 1999-07-15 2001-01-25 Kuhnil Pharm. Co., Ltd. Nouveaux composes conjugues a base de cyclosporine hydrosoluble
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
US6352996B1 (en) 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US6713454B1 (en) 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs
US6541508B2 (en) 1999-09-13 2003-04-01 Nobex Corporation Taxane prodrugs
US6380405B1 (en) 1999-09-13 2002-04-30 Nobex Corporation Taxane prodrugs
US6376470B1 (en) * 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
WO2001024763A2 (fr) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions et methodes de traitement du cancer utilisant des immunoconjugues et des agents chimiotherapeutiques
MXPA02006216A (es) 1999-12-22 2004-02-26 Nektar Therapeutics Al Corp Derivados estericamente impedidos de polimeros solubles en agua.
AU2001257577A1 (en) 2000-02-28 2001-09-03 Shearwater Corporation Water-soluble polymer conjugates of artelinic acid
AU2001268228A1 (en) 2000-06-08 2001-12-17 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide
RU2003104024A (ru) * 2000-07-12 2004-06-27 Грифон Терапьютикс, Инк. (Us) Полимер-модифицированные биоактивные синтетические хемокины и способы их приготовления и применения
US7118737B2 (en) 2000-09-08 2006-10-10 Amylin Pharmaceuticals, Inc. Polymer-modified synthetic proteins
US20030191291A1 (en) * 2000-09-08 2003-10-09 Kochendoerfer Gerd G. Synthetic erythropoiesis stimulating proteins
US7829074B2 (en) * 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
US6436386B1 (en) 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
EP1361895B1 (fr) * 2001-02-20 2007-11-14 Enzon, Inc. Lieurs polymeriques a ramification terminale et conjugues polymeriques contenant ceux-ci
ATE378342T1 (de) * 2001-02-20 2007-11-15 Enzon Inc Terminal verzweigte, polymere linker und diese enthaltende polymere konjugate
US20040077835A1 (en) * 2001-07-12 2004-04-22 Robin Offord Chemokine receptor modulators, production and use
AU2002363334A1 (en) * 2001-11-09 2003-05-19 Enzon, Inc. Polymeric thiol-linked prodrugs
GB0202906D0 (en) 2002-02-07 2002-03-27 Univ London Prevention of myocardial damage
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
JP4272537B2 (ja) * 2002-03-13 2009-06-03 北京鍵▲凱▼科技有限公司 Ｙ型分鎖親水性ポリマー誘導体、それらの調製方法、前記誘導体および薬剤分子の結合生成物、ならびに前記結合生成物を含む医薬組成物
AU2003226166A1 (en) * 2002-04-04 2003-10-20 Enzon, Inc. Polymeric acyl derivatives of indoles
CN100393724C (zh) * 2002-07-12 2008-06-11 中国医学科学院药物研究所 20-位酯化的喜树碱衍生物及其制法和其药物组合物与用途
KR100974843B1 (ko) 2002-09-09 2010-08-11 넥타르 테라퓨틱스 수용성 중합체 알카날
JP4959133B2 (ja) 2002-09-09 2012-06-20 ネクター セラピューティックス 末端カルボン酸またはそのエステルを有する水溶性ポリマー誘導体の調製方法
MXPA05002593A (es) * 2002-09-11 2005-05-27 Fresenius Kabi Gmbh Metodo para producir derivados del almidon de hidroxialquilo.
US8129330B2 (en) * 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040062748A1 (en) * 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
CN1309763C (zh) 2002-10-31 2007-04-11 日本化药株式会社 喜树碱的高分子衍生物
AU2003303595A1 (en) 2002-12-30 2004-07-29 Gryphon Therapeutics, Inc. Water-soluble thioester and selenoester compounds and methods for making and using the same
EP1603512A2 (fr) * 2003-03-17 2005-12-14 Albany Molecular Research, Inc. Nouvelles cyclosporines
NZ541374A (en) * 2003-05-23 2008-09-26 Nektar Therapeutics Al Corp PEG derivatives having an amidocarbonate linkage
US7947261B2 (en) 2003-05-23 2011-05-24 Nektar Therapeutics Conjugates formed from polymer derivatives having particular atom arrangements
US7342114B2 (en) * 2003-07-01 2008-03-11 California Pacific Medical Center Podophyllotoxin derivatives
WO2005014655A2 (fr) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugues d'amidon d'hydroxyalkyle et de proteine
US20080274948A1 (en) * 2003-08-08 2008-11-06 Fresenius Kabi Deutschland Gmbh Conjugates of Hydroxyalkyl Starch and G-Csf
HRP20171094T1 (hr) * 2003-09-17 2017-10-06 Nektar Therapeutics Višestruko razgranati polimerni prolijekovi
US8394365B2 (en) 2003-09-17 2013-03-12 Nektar Therapeutics Multi-arm polymer prodrugs
JP2007521338A (ja) * 2004-01-07 2007-08-02 アンビット バイオサイエンシス コーポレーション 共役化された低分子
EP1756173B1 (fr) * 2004-01-21 2019-04-03 Nektar Therapeutics Procede permettant de preparer des polymeres a terminaison d'acide propionique
WO2005092391A2 (fr) * 2004-03-11 2005-10-06 Fresenius Kabi Deutschland Gmbh Conjugues d'amidon hydroxyalkyle et de proteine, par ligature chimique naturelle
TWI417303B (zh) 2004-03-11 2013-12-01 Fresenius Kabi De Gmbh 經由還原胺化作用製得之羥烷基澱粉及蛋白質的接合物
AU2005230994A1 (en) * 2004-04-09 2005-10-20 Chugai Seiyaku Kabushiki Kaisha Novel water-soluble prodrug
US8614228B2 (en) 2004-08-11 2013-12-24 Arqule, Inc. Quinone prodrug compositions and methods of use
EP1877097B1 (fr) 2004-08-11 2012-06-20 Arqule, Inc. Conjugués d'acides aminés et de bêta-lapachone pour le ciblage de tumeurs
PT1792927E (pt) 2004-09-22 2013-05-15 Nippon Kayaku Kk Novo copolímero em bloco, preparação de micelas e agente anticancerígeno contendo o mesmo como ingrediente activo
US7378391B2 (en) * 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
WO2006039164A2 (fr) * 2004-09-29 2006-04-13 Amr Technology, Inc. Nouveaux analogues de la cyclosporine et leurs utilisations pharmaceutiques
EP1812037A4 (fr) * 2004-10-06 2009-11-11 Amr Technology Inc Alcynes de cyclosporine, et leur utilite comme agents pharmaceutiques
EP1854474A4 (fr) 2005-01-31 2012-04-04 Eci Inc Agent immunostimulant
EP1861124A2 (fr) * 2005-03-11 2007-12-05 Fresenius Kabi Deutschland GmbH Production de glycoproteines bioactives a partir d'un materiau de depart inactif
WO2006097682A1 (fr) * 2005-03-18 2006-09-21 Ucl Business Plc Peptides du facteur de mecano-croissance et leur utilisation
EP2279756A2 (fr) 2005-04-05 2011-02-02 Instituto di Ricerche di Biologia Molecolare p Angeletti S.P.A. Procédé de protection de sites fonctionnels ou épitopes sur les protéines
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
EP1762250A1 (fr) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Conjugués d' amidon hydroxyalkyle et une substance active obtenue par ligation chimique via thiazolidine
JP5096363B2 (ja) * 2005-12-16 2012-12-12 ネクター セラピューティックス Ｇｌｐ−１のポリマ複合体
US7671067B2 (en) * 2006-02-09 2010-03-02 Enzon Pharmaceuticals, Inc. Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin
US7462627B2 (en) * 2006-02-09 2008-12-09 Enzon Pharmaceuticals, Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
CN101420984B (zh) 2006-02-21 2013-01-02 尼克塔治疗公司 嵌段可降解聚合物及由其制备的轭合物
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US8323669B2 (en) 2006-03-28 2012-12-04 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of taxane
JP5313129B2 (ja) 2006-05-02 2013-10-09 アロザイン， インコーポレイテッド 非天然アミノ酸置換ポリペプチド
US20080096819A1 (en) * 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
CN101448875A (zh) 2006-05-18 2009-06-03 日本化药株式会社 鬼臼毒素类的高分子量结合体
WO2008034019A2 (fr) 2006-09-13 2008-03-20 Polymerix Corporation Agents actifs et oligomères et polymères de ceux-ci
US8110559B2 (en) * 2006-09-15 2012-02-07 Enzon Pharmaceuticals, Inc. Hindered ester-based biodegradable linkers for oligonucleotide delivery
KR20090083334A (ko) * 2006-09-15 2009-08-03 엔존 파마슈티컬즈, 인코포레이티드 방해된 에스테르 기재 생분해성 링커를 갖는 폴리알킬렌 옥시드
AU2007296190A1 (en) * 2006-09-15 2008-03-20 Enzon Pharmaceuticals, Inc. Lysine-based polymeric linkers
US7985783B2 (en) 2006-09-21 2011-07-26 The Regents Of The University Of California Aldehyde tags, uses thereof in site-specific protein modification
WO2008041610A1 (fr) * 2006-10-03 2008-04-10 Nippon Kayaku Kabushiki Kaisha Mélange d'un dérivé de résorcinol avec un polymère
WO2008056596A1 (fr) 2006-11-06 2008-05-15 Nippon Kayaku Kabushiki Kaisha Dérivé polymère d'un antagoniste métabolique d'acide nucléique
US8188222B2 (en) 2006-11-08 2012-05-29 Nippon Kayaku Kabushiki Kaisha High molecular weight derivative of nucleic acid antimetabolite
WO2008066902A2 (fr) 2006-11-30 2008-06-05 Nektar Therapeutics Al, Corporation Procédé de préparation d'un conjugué de polymère
CA2677798A1 (fr) * 2007-02-09 2008-08-14 Enzon Pharmaceuticals, Inc. Traitement de cancers resistants ou refractaires avec des conjugues polymeres multibrins de 7-ethyl-10-hydroxycamptothecine
JP2010526072A (ja) * 2007-04-30 2010-07-29 アークル インコーポレイテッド キノン化合物のヒドロキシスルホナートおよびその使用
CA2707840A1 (fr) * 2007-08-20 2009-02-26 Allozyne, Inc. Molecules substituees par des acides amines
CA2695532A1 (fr) * 2007-08-20 2009-02-26 Enzon Pharmaceuticals, Inc. Liants polymeres contenant des groupes disulfures de pyridyle
EP2206502B1 (fr) 2007-09-28 2018-09-12 Nippon Kayaku Kabushiki Kaisha Conjugué polymère-stéroïde
JP5823125B2 (ja) 2007-10-23 2015-11-25 ウェルズ ファーゴ バンク ナショナル アソシエイション ヒドロキシアパタイト標的化多腕ポリマーならびに、このポリマーから作られるコンジュゲート
EP2070951A1 (fr) * 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Procédé de production d'un dérivé hydroxyalkyle de l'amidon avec deux liens
EP2070950A1 (fr) * 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Dérivés hydroxyalkylés de l'amidon et leur procédé de préparation
KR101589582B1 (ko) 2008-03-18 2016-01-28 니폰 가야꾸 가부시끼가이샤 생리활성물질의 고분자량 결합체
JP5366940B2 (ja) 2008-05-08 2013-12-11 日本化薬株式会社 葉酸若しくは葉酸誘導体の高分子結合体
JP5588983B2 (ja) 2008-08-11 2014-09-10 ウェルズ ファーゴ バンク ナショナル アソシエイション マルチアームポリマーアルカノエートコンジュゲート
US20100056555A1 (en) * 2008-08-29 2010-03-04 Enzon Pharmaceuticals, Inc. Method of treating ras associated cancer
WO2010033224A1 (fr) * 2008-09-19 2010-03-25 Nektar Therapeutics Conjugués de polymère de peptides kiss1
US20110171161A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Polymer conjugates of protegrin peptides
US20110165112A1 (en) * 2008-09-19 2011-07-07 Nektar Therapeutics Polymer conjugates of c-peptides
US8449872B2 (en) * 2008-09-19 2013-05-28 Nektar Therapeutics Polymer conjugates of nesiritide peptides
US20110171165A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Polymer conjugates of opioid growth factor peptides
WO2010033205A1 (fr) * 2008-09-19 2010-03-25 Nektar Therapeutics Conjugués polymères de peptides analogues à v-681
EP2340046A2 (fr) * 2008-09-19 2011-07-06 Nektar Therapeutics Conjugués polymères de peptides ziconotides
US20110171162A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Polymer conjugates of thymosin alpha 1 peptides
US20110171166A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Polymer conjugates of osteocalcin peptides
EP2340050A2 (fr) * 2008-09-19 2011-07-06 Nektar Therapeutics Conjugués polymères de peptides de type aod
WO2010042145A1 (fr) * 2008-09-19 2010-04-15 Nektar Therapeutics Conjugués polymères de peptides de type glp-2
WO2010033207A1 (fr) 2008-09-19 2010-03-25 Nektar Therapeutics Conjugués polymères de peptides thérapeutiques
HRP20192120T1 (hr) 2008-09-23 2020-02-21 Nektar Therapeutics Postupak metronomskog doziranja kamptotecinskih prolijekova (e.g.peg-irinotekan)
US20100098654A1 (en) * 2008-10-21 2010-04-22 Fabio Pastorino Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
US8808749B2 (en) 2009-05-15 2014-08-19 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of bioactive substance having hydroxy group
MX2012013375A (es) 2010-05-17 2013-04-11 Cebix Inc Peptido c pegilado.
US20130178437A1 (en) 2010-07-09 2013-07-11 Fresenius Kabi Deutschland Gmbh Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation
WO2012004008A1 (fr) 2010-07-09 2012-01-12 Fresenius Kabi Deutschland Gmbh Conjugués comprenant un amidon hydroxyalkylé et un agent cytotoxique et leur procédé de préparation
US20140073779A9 (en) 2010-07-09 2014-03-13 Fresenius Kabi Deutschland Gmbh Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation
WO2012004009A1 (fr) 2010-07-09 2012-01-12 Fresenius Kabi Deutschland Gmbh Conjugués comprenant de l'hydroxyalkylamidon et un agent cytotoxique et leur procédé de synthèse
CN102339813A (zh) 2010-07-14 2012-02-01 中国科学院微电子研究所 半导体结构及其制造方法
TW201304805A (zh) 2010-11-17 2013-02-01 Nippon Kayaku Kk 新穎之胞核苷系代謝拮抗劑之高分子衍生物
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (fr) 2010-12-22 2012-06-28 Nektar Therapeutics Conjugués promédicaments polymères à plusieurs bras de composés à base de taxane
HRP20201998T1 (hr) * 2011-06-06 2021-02-05 Starpharma Pty Ltd Makromolekule
PL2717917T3 (pl) 2011-07-05 2016-12-30 Koniugaty p97 - przeciwciało
CN103874722B (zh) 2011-09-11 2016-06-29 日本化药株式会社 嵌段共聚物的制造方法
CN103083680B (zh) 2011-11-07 2014-12-24 北京键凯科技有限公司 聚乙二醇-氨基酸寡肽-依诺替康药物结合物及其药物组合物
SG10201912411RA (en) 2011-12-28 2020-02-27 Univ California Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
HK1203412A1 (en) 2011-12-28 2015-10-30 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
EP2880156B1 (fr) 2012-07-31 2017-08-23 biOasis Technologies Inc Protéines de maladie de stockage lysosomal déphosphorylées et leurs procédés d'utilisation
EP2916835A4 (fr) 2012-11-12 2016-07-27 Redwood Bioscience Inc Composés et procédés pour produire un conjugué
JP2016505528A (ja) 2012-11-16 2016-02-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア タンパク質の化学修飾のためのピクテ−スペングラーライゲーション
US9310374B2 (en) 2012-11-16 2016-04-12 Redwood Bioscience, Inc. Hydrazinyl-indole compounds and methods for producing a conjugate
US9364567B2 (en) 2013-03-13 2016-06-14 Bioasis Technologies, Inc. Fragments of p97 and uses thereof
EP2970196B1 (fr) 2013-03-15 2020-11-25 Global Blood Therapeutics, Inc. Composés et leurs utilisations pour la modulation de l'hémoglobine
BR112015021982B1 (pt) 2013-03-15 2022-12-13 Global Blood Therapeutics, Inc Compostos e seus usos para a modulação de hemoglobina
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR20150132146A (ko) 2013-03-15 2015-11-25 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EP3038657A2 (fr) 2013-08-28 2016-07-06 Bioasis Technologies Inc. Conjugués comportant des régions fc modifiées pour cibler le snc et méthodes pour les utiliser
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
EP4592275A3 (fr) 2013-11-27 2025-10-29 Redwood Bioscience, Inc. Composés hydrazinyl-pyrrolo et procédés de production d'un conjugué
FI3102208T4 (fi) 2014-02-07 2024-09-23 Global Blood Therapeutics Inc 2-hydroksi-6-((2-(1-isopropyyli-1h-pyratsol-5-yyli)pyridin-3-yyli)metoksi)bentsaldehydin vapaan emäksen kiteinen polymorfi
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
US10087194B2 (en) 2015-10-27 2018-10-02 California Pacific Medical Center Podophyllotoxin derivatives and their use
CN106937529B (zh) 2015-10-27 2021-02-05 加州太平洋医疗中心 鬼臼毒素衍生物及其应用
MX2018005785A (es) 2015-11-09 2019-04-04 Scherer Technologies Llc R P Conjugados de anticuerpo anti-cd22-maytansina y metodos de uso de los mismos.
WO2017096230A1 (fr) 2015-12-04 2017-06-08 Global Blood Therapeutics, Inc. Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
ES3001139T3 (es) 2016-04-15 2025-03-04 Beckman Coulter Inc Macromoléculas fotoactivas y usos de las mismas
AR108435A1 (es) 2016-05-12 2018-08-22 Global Blood Therapeutics Inc Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
KR20220147719A (ko) 2016-11-14 2022-11-03 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
EP3609527B1 (fr) 2017-03-29 2025-07-30 Polaris Group Conjugués de protéines
US11492493B2 (en) 2017-12-26 2022-11-08 Becton, Dickinson And Company Deep ultraviolet-excitable water-solvated polymeric dyes
CN112384573A (zh) 2018-03-30 2021-02-19 贝克顿·迪金森公司 含侧基发色团的水溶性聚合染料
WO2020014750A1 (fr) 2018-07-19 2020-01-23 Starpharma Pty Ltd Dendrimère thérapeutique
US12071517B2 (en) 2018-07-19 2024-08-27 Starpharma Pty Ltd. Therapeutic dendrimer
EP3813867A1 (fr) 2018-07-22 2021-05-05 Bioasis Technologies Inc. Traitement de métastases lymphatiques
EP4438618A3 (fr) * 2018-08-22 2025-01-01 Bacainn Biotherapeutics, Ltd. Compositions de cyclosporine et méthodes d'utilisation
CN110862400A (zh) * 2018-08-27 2020-03-06 遵义医学院 喜树碱-羟基乙酸中间体的制备工艺
ES2966707T3 (es) 2018-10-01 2024-04-23 Global Blood Therapeutics Inc Moduladores de la hemoglobina para el tratamiento de la drepanocitosis
WO2020163689A1 (fr) 2019-02-08 2020-08-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Inhibiteurs de formation de 20-hete
US20210355468A1 (en) 2020-05-18 2021-11-18 Bioasis Technologies, Inc. Compositions and methods for treating lewy body dementia
US20210393787A1 (en) 2020-06-17 2021-12-23 Bioasis Technologies, Inc. Compositions and methods for treating frontotemporal dementia
CA3128035A1 (fr) 2020-08-13 2022-02-13 Bioasis Technologies, Inc. Polytherapies pour l'administration dans l'ensemble de la barriere hemato-encephalique
EP4155349A1 (fr) 2021-09-24 2023-03-29 Becton, Dickinson and Company Colorants absorbants jaunes verts solubles dans l'eau
WO2022078524A2 (fr) 2021-11-03 2022-04-21 Hangzhou Dac Biotech Co., Ltd. Conjugaison spécifique d'un anticorps
AU2023298234A1 (en) 2022-07-01 2025-01-16 Beckman Coulter, Inc. Novel fluorescent dyes and polymers from dihydrophenanthrene derivatives
WO2024044327A1 (fr) 2022-08-26 2024-02-29 Beckman Coulter, Inc. Monomères dhnt et colorants polymères ayant des propriétés photophysiques modifiées
CN120936679A (zh) 2023-03-17 2025-11-11 贝克曼库尔特有限公司 苯并噻吩并吡咯花菁染料
WO2025064842A1 (fr) 2023-09-21 2025-03-27 Beckman Coulter, Inc. Colorants pontés par dihydrophénanthrène (dhp) destinés à être utilisés en cytométrie en flux

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
DE3675588D1 (de) * 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
JP2534849B2 (ja) * 1986-09-06 1996-09-18 タイホー工業株式会社 磁性体生理活性物質複合体
US5157075A (en) * 1990-05-02 1992-10-20 Taenaka Mining Co., Ltd. Modified melanin
US5284864A (en) * 1991-09-23 1994-02-08 Florida State University Butenyl substituted taxanes and pharmaceutical compositions containing them
WO1993024476A1 (fr) * 1992-06-04 1993-12-09 Clover Consolidated, Limited Vehicules polymeres solubles dans l'eau servant a la liberation de medicaments
GB9213077D0 (en) * 1992-06-19 1992-08-05 Erba Carlo Spa Polymerbound taxol derivatives
US5614549A (en) * 1992-08-21 1997-03-25 Enzon, Inc. High molecular weight polymer-based prodrugs
WO1994005282A1 (fr) * 1992-09-04 1994-03-17 The Scripps Research Institute Derives de taxol hydrosolubles
US5298643A (en) * 1992-12-22 1994-03-29 Enzon, Inc. Aryl imidate activated polyalkylene oxides
US5321095A (en) * 1993-02-02 1994-06-14 Enzon, Inc. Azlactone activated polyalkylene oxides
US5547981A (en) * 1993-03-09 1996-08-20 Enzon, Inc. Taxol-7-carbazates
AU6361294A (en) * 1993-03-09 1994-09-26 Enzon, Inc. Taxol-based compositions with enhanced bioactivity
JPH09504033A (ja) * 1993-10-20 1997-04-22 エンゾン，インコーポレーテッド ２’−及び／又は７−置換タキソイド類
US5880131A (en) * 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5489589A (en) * 1994-12-07 1996-02-06 Bristol-Myers Squibb Company Amino acid derivatives of paclitaxel

Also Published As

Publication number Publication date
JP5008783B2 (ja) 2012-08-22
US5840900A (en) 1998-11-24
EP0923566A4 (fr) 2001-10-10
DK0923566T3 (da) 2004-03-08
ES2210564T3 (es) 2004-07-01
AU4079497A (en) 1998-03-06
CA2263409A1 (fr) 1998-02-26
EP0923566B1 (fr) 2003-10-29
DE69725862D1 (de) 2003-12-04
CA2263409C (fr) 2011-02-22
ATE253060T1 (de) 2003-11-15
JP2000517304A (ja) 2000-12-26
NZ334283A (en) 2000-03-27
EP0923566A1 (fr) 1999-06-23
AU730244B2 (en) 2001-03-01
PT923566E (pt) 2004-03-31
DE69725862T2 (de) 2004-08-19
WO1998007713A1 (fr) 1998-02-26
JP2010100628A (ja) 2010-05-06

Similar Documents

Publication Publication Date Title
SI0923566T1 (en) High molecular weight polymer-based prodrugs
MX9705748A (es) Profarmacos a base de polimero de peso molecular alto.
TW327648B (en) Thickened aqueous compositions and use thereof
EP0909789A3 (fr) Composition comprenant du poly(3-hydroxyalcanoates)
AU3141693A (en) Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them
EA200100838A1 (ru) Конъюгаты гксф
AU2647495A (en) Novel potent inducers of terminal differentiation and methods of use thereof
FI871630A0 (fi) Lianpoistoaineena käyttökelpoisia, pääteryhmiä sisältäviä 1,2-propyleenitereftalaatti-polyoksietyleeni-tereftalaatti-polyestereitä ja niitä sisältäviä yhdistelmiä
AU8729791A (en) Pharmaceutical formulations
NZ508301A (en) Polyethylene glycol-polyorthoester, polyethylene glycol-polyorthoester-polyethylene glycol, and polyorthoester-polyethylene glycol-polyorthoester block copolymers
DK10888D0 (da) Forbedret fibrinolytisk forbindelse
DE69328741D1 (de) Unvernetztes Anion-Austauscherharz und diesen enthaltende pharmazeutische Zusammensetzung
MX9803656A (es) Compuesto, preparacion y uso.
YU71091A (sh) Antiinflamatorne hidroksamske kiseline i n-hidroksikarbamidi
TW261616B (fr)
GR3017051T3 (en) Azeotropic or azeotropic-like composition of hydrochlorofluoropropane.
CA2062779A1 (fr) Melange gazeux pour la sterilisation comprenant du monochlorotetrafluoroethane et de l'oxyde d'ethylene
ES2163396T3 (es) Aminas biologicamente activas.
TW334434B (en) Novel quinazoline compound and anti-tumor agent
FI891581A0 (fi) Peptidderivat.
IE45607L (en) Psychopharmacologically active peptides
CA2152910A1 (fr) Monomere acrylique cycloaliphatique
ATE187484T1 (de) Waschmittelzusammensetzungen mit oleoylsarcosinate und polymeres dispergiermittel
MY106233A (en) Detergent composition.
MY111439A (en) Thymosin alpha 1 derivatives